EUVIMEDEUVIMED entdecken
Open Access

Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease

Hiroyuki Fujii iD, Yu Taniguchi iD, Sachiyo Yoneda iD, Keisuke Miwa, Yoichiro Matsuoka iD, Kenichi Yanaka, Yasunori Tsuboi iD, Noriaki Emoto iD, Kenichi Hirata

Journal of the American Heart Association · 2023

DOI: 10.1161/jaha.122.026466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Hiroyuki Fujii und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Embolism, Angioplasty, Balloon, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Balloon pulmonary angioplasty (BPA) is a promising treatment modality for nonoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, BPA for atypical CTEPH with concurrent chronic obstructive pulmonary disease (COPD) remains controversial owing to the risk of exacerbation of ventilation‐perfusion mismatch. We aimed to evaluate the efficacy and safety of BPA for CTEPH with moderate or severe COPD. Methods and Results Data from 149 patients with CTEPH, who underwent BPA from March 2011 to June 2021, were retrospectively analyzed. Patients were divided based on COPD comorbidity: the COPD group (n=32, defined as forced expiratory volume in 1 second/forced vital capacity

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryPulmonary EmbolismAngioplasty, BalloonPulmonary Disease, Chronic ObstructiveHumansRetrospective StudiesChronic DiseaseComorbidityLungPulmonary ArteryTreatment Outcome

Stichwörter der Autor:innen

balloon pulmonary angioplastychronic obstructive pulmonary diseasechronic thromboembolic pulmonary hypertension

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

ORCID-Profile: Hiroyuki Fujii, Yu Taniguchi, Sachiyo Yoneda, Yoichiro Matsuoka, Yasunori Tsuboi, Noriaki Emoto

Zitieren

APA

Fujii, H., Taniguchi, Y., Yoneda, S., Miwa, K., Matsuoka, Y., Yanaka, K., Tsuboi, Y., Emoto, N., & Hirata, K. (2023). Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.122.026466

Vancouver

Fujii H, Taniguchi Y, Yoneda S, Miwa K, Matsuoka Y, Yanaka K, et al. Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease. Journal of the American Heart Association. 2023. doi:10.1161/jaha.122.026466

BibTeX
@article{Fujii2023,
  author = {Fujii, Hiroyuki and Taniguchi, Yu and Yoneda, Sachiyo and Miwa, Keisuke and Matsuoka, Yoichiro and Yanaka, Kenichi and Tsuboi, Yasunori and Emoto, Noriaki and Hirata, Kenichi},
  title = {Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease},
  journal = {Journal of the American Heart Association},
  year = {2023},
  doi = {10.1161/jaha.122.026466}
}
Kostenlos starten →